AS

Arjun Sharma

Active Director Director DIN 03192936
DIN 03192936 First appointment Aug 2010 Primary industry FMCG
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2010
Shareholding value •••• Premium profile

About Arjun Sharma

Data last updated:

Arjun Sharma is a Director at Jmd Pharmaceuticals Private Limited (since 2010). The company operates in FMCG. Jmd Pharmaceuticals Private Limited reported revenue of ₹1.95 Cr (FY 2025).

DIN 03192936
Primary Designation Director
Industry FMCG
First Appointment 20 Aug 2010
Oldest Company Age 35 yrs
Largest company Jmd Pharmaceuticals Private Limited · ₹1.95 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jmd Pharmaceuticals Private Limited U24231UP1991PTC012763
Director20 Aug 20101991₹1.95 Cr (FY 2025)Active

Board colleagues of Arjun Sharma

Directorship timeline

Open interactive timeline →
Jmd Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Arjun Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arjun Sharma

Arjun Sharma currently holds 1 directorship: Jmd Pharmaceuticals Private Limited (Director, since 20 Aug 2010, revenue ₹1.95 Cr (FY 2025)).

Arjun Sharma was first appointed on 20 Aug 2010 as Director at Jmd Pharmaceuticals Private Limited.

The current boards of Arjun Sharma's companies include Raj Kumar (Jmd Pharmaceuticals Private Limited), Vinod Kumar (Jmd Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available